Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer

The choice of adjuvant systemic therapy is based on targeted therapy in line with the St. Gallen Consensus meeting. In addition to the traditional parameters, the panel recommended the use of proliferation markers and multigene assays. The purpose of the present study was to evaluate the clinical si...

Full description

Saved in:
Bibliographic Details
Main Authors: NISHIMURA, REIKI, OSAKO, TOMOFUMI, OKUMURA, YASUHIRO, HAYASHI, MITSUHIRO, TOYOZUMI, YASUO, ARIMA, NOBUYUKI
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2010
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3445951/
https://ncbi.nlm.nih.gov/pubmed/22993598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2010.133
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items